Skip to content
October 01, 2022

Equity.Guru

Investment information for the new generation

VPH.C

Valeo Pharma (VPH.C) has gotten their their Hesperco flavonoid formulation on shelves at over 300 stores under the Loblaws brand, including Loblaws, Dominion, Zehs, Fortinios, Your Independent Grocer and…
Valeo Pharma Inc. (VPH.C) announced today that it has successfully entered into a Product Listing Agreement (PLA) with the Quebec Minister of Health. According to this agreement, the Company…
Even during my university days, I would find myself grasping my chest, wheezing after a short 15-minute walk to campus. In terms of fitness, I would consider myself to…
In this episode, we revisit Valeo Pharma (VPH.C) to get an update on their product portfolio, stock price, and financials. Is VPH.C a good long term investment? Tune In!…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company, engages in the acquisition, in-licensing, and commercialization of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Valeo Pharma (VPH.C) is a specialty pharmaceutical company that sources, acquires, or in-licenses brand and generic products for sale in Canada. Valeo’s business objective is to become an anchor…
Jody catches up with the CEO of Valeo Pharma (VPH.C), Steve Saviuk, to talk more about their specialty product. Redesca, and Asthma products, Enerzair® breezhaler® and Atectura® breezhaler®. Based…
Valeo (VPH.C), a specialty pharma company, announced early today that it has obtained listings for Redesca from two group purchasing organizations (“GPO”) on behalf of +700 hospitals and health…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…